Yuwei Li - Publications

Novel environmental contaminant 6PPD-quinone promotes malignant phenotypes in colorectal cancer cells and identifies candidate response-associated genes.

Journal: Chemico-biological interactions

Published: June 15, 2026

A multidimensional pan-cancer analysis of CD47 and its role in promoting malignant phenotype in pancreatic adenocarcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 26, 2025

Dysregulated programmed cell death of intestinal epithelial cells in ulcerative colitis: Molecular mechanisms and novel therapeutic interventions (Review).

Journal: International journal of molecular medicine

Published: June 27, 2025

Bone marrow mesenchymal stem cell-derived exosomes alleviate DSS-induced inflammatory bowel disease in mice through inhibiting intestinal epithelial cell pyroptosis via delivery of TSG-6.

Journal: Frontiers in immunology

Published: March 28, 2025

Chronic pharyngitis and cervical spondylosis risk: A bidirectional Mendelian randomization study.

Journal: Medicine

Published: February 24, 2025

Long non-coding RNA NEAT1 promotes colorectal cancer progression via interacting with SIRT1.

Journal: Scientific reports

Published: August 13, 2024

Pan-cancer analysis and single-cell analysis reveals FAM110B as a potential target for survival and immunotherapy.

Journal: Frontiers in molecular biosciences

Published: April 27, 2024

Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‑1 pathway activity: Integrating animal experiments and network pharmacology.

Journal: Molecular medicine reports

Published: November 30, 2023

Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer.

Journal: Exploration (Beijing, China)

Published: September 30, 2023